OA08971A - Structures peptidiques, immunogènes les contenant et leurs applications au contrôle de la fertilité - Google Patents

Structures peptidiques, immunogènes les contenant et leurs applications au contrôle de la fertilité

Info

Publication number
OA08971A
OA08971A OA59480A OA59480A OA08971A OA 08971 A OA08971 A OA 08971A OA 59480 A OA59480 A OA 59480A OA 59480 A OA59480 A OA 59480A OA 08971 A OA08971 A OA 08971A
Authority
OA
OAPI
Prior art keywords
applications
peptide structures
fertility control
immunogens containing
immunogens
Prior art date
Application number
OA59480A
Other languages
English (en)
French (fr)
Original Assignee
Lafon Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Pharma filed Critical Lafon Pharma
Publication of OA08971A publication Critical patent/OA08971A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA59480A 1987-11-26 1988-11-25 Structures peptidiques, immunogènes les contenant et leurs applications au contrôle de la fertilité OA08971A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716420A FR2623715B1 (fr) 1987-11-26 1987-11-26 Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite

Publications (1)

Publication Number Publication Date
OA08971A true OA08971A (fr) 1990-11-30

Family

ID=9357207

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59480A OA08971A (fr) 1987-11-26 1988-11-25 Structures peptidiques, immunogènes les contenant et leurs applications au contrôle de la fertilité

Country Status (22)

Country Link
US (1) US5496551A (de)
EP (1) EP0323769B1 (de)
JP (1) JP2509312B2 (de)
KR (1) KR890008171A (de)
CN (1) CN1034208A (de)
AP (1) AP71A (de)
AT (1) ATE102957T1 (de)
AU (1) AU617716B2 (de)
DE (1) DE3888509T2 (de)
DK (1) DK660888A (de)
EG (1) EG18596A (de)
ES (1) ES2052762T3 (de)
FR (1) FR2623715B1 (de)
IE (1) IE883545L (de)
IL (1) IL88381A (de)
MA (1) MA21448A1 (de)
NO (1) NO885231L (de)
NZ (1) NZ227073A (de)
OA (1) OA08971A (de)
PT (1) PT89053B (de)
TN (1) TNSN88129A1 (de)
ZA (1) ZA888733B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9001709A (nl) * 1990-07-27 1992-02-17 Stichting Centr Diergeneeskund Peptiden en farmaceutische preparaten met een glycoprotene hormoon agonistische of antagonistische werking.
FR2710845B1 (fr) * 1993-10-08 1996-03-29 Lafon Labor Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
FR2702494B1 (fr) * 1993-03-11 1995-06-09 Lafon Labor Trousse de diagnostic d'un cancer secrétant l'hCG ou des fragments d'hCG et vaccin destiné à l'immunothérapie d'un tel cancer.
EP0688432A1 (de) * 1993-03-11 1995-12-27 Laboratoire L. Lafon Diagnose sätze für einen hcg oder hcg-fragmente sekretierenden krebs und mittel für die immunotherapie eines solchen krebs
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
IL140984A0 (en) * 1998-07-23 2002-02-10 Lilly Co Eli Fsh and fsh variant formulations, products and methods
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
WO2026006438A1 (en) * 2024-06-26 2026-01-02 The Regents Of The University Of California Non-surgical, injectable sterilant for dogs and cats

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4384995A (en) * 1980-01-16 1983-05-24 The Ohio State University Antigenic modification of polypeptides
DK159276C (da) * 1980-03-31 1991-02-18 Takeda Chemical Industries Ltd Fremgangsmaade til isolering af specifikke antistoffer og enzym-immunbestemmelsesmetode med anvendelse af det isolerede antistof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
EP0142387A1 (de) * 1983-08-26 1985-05-22 Anda Biologicals Verfahren zur Herstellung von spezifischen Impfstoffen für LH und HCG und Verfahren für ihre Entdeckung
WO1986007383A1 (en) * 1985-06-04 1986-12-18 Biotechnology Research Partners, Ltd. Autoantigen vaccines
CA1239346A (en) * 1985-06-04 1988-07-19 National Institute Of Immunology Birth control vaccine
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides

Also Published As

Publication number Publication date
JPH01301696A (ja) 1989-12-05
EP0323769B1 (de) 1994-03-16
AU617716B2 (en) 1991-12-05
CN1034208A (zh) 1989-07-26
IL88381A0 (en) 1989-06-30
PT89053B (pt) 1993-04-30
TNSN88129A1 (fr) 1990-07-10
US5496551A (en) 1996-03-05
EP0323769A1 (de) 1989-07-12
MA21448A1 (fr) 1989-07-01
EG18596A (en) 1993-07-30
AP71A (en) 1990-02-24
KR890008171A (ko) 1989-07-10
NZ227073A (en) 1990-06-26
PT89053A (pt) 1988-12-01
IL88381A (en) 1993-03-15
ZA888733B (en) 1990-08-29
AP8800110A0 (en) 1989-01-31
ATE102957T1 (de) 1994-04-15
JP2509312B2 (ja) 1996-06-19
AU2596888A (en) 1989-06-01
DK660888A (da) 1989-05-27
DK660888D0 (da) 1988-11-25
NO885231D0 (no) 1988-11-24
ES2052762T3 (es) 1994-07-16
FR2623715B1 (fr) 1990-12-21
NO885231L (no) 1989-05-29
FR2623715A1 (fr) 1989-06-02
DE3888509T2 (de) 1994-10-06
DE3888509D1 (de) 1994-04-21
IE883545L (en) 1989-05-26

Similar Documents

Publication Publication Date Title
DE3586313D1 (de) Konjugate von pharmazeutisch nuetzlichen proteinen.
DE3672924D1 (de) Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen.
DE3889401D1 (de) Verkapselung von Hilfsstoffen in Antischweissmitteln.
DK38989A (da) Dna-sekvens
ES2043609T3 (es) Composiciones de interleucina-2.
DE3580717D1 (de) Pharmazeutische anwendung von (nva)2-cyclosporine.
DE3876997D1 (de) Konjugate von superoxiddismutase.
FR2623715B1 (fr) Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
DK254385A (da) Blodposesystem
MA20407A1 (fr) Derives de l'hydroxy-4-2h-1-benzothiopyran-2-one,leurs preparations et applications
FI880032A0 (fi) Vaetskeringspump i tvao steg.
DE3586765D1 (de) Immunogenische hav-peptide.
FI892132A0 (fi) Prolaekemedel av 2',3'-didehydro-2' 3'-dideoxynukleosider.
FI900008A7 (fi) Ristikkopalkki
DE3855571D1 (de) Verstärkungsregelungsanlage
FR2567125B1 (fr) Acides dihydro-5,6-4h-cyclopenta (b) thiophenecarboxylique-6, procedes de preparation et medicaments les contenant
FR2631626B1 (fr) Nouveaux pentapeptides et leurs applications en tant que medicaments, notamment antithrombotiques
FR2500823B1 (fr) 1-aminoalkyl-1, 2, 3, 4-tetrahydroanphtalenes mono- ou disubstitues utiles notamment comme adrenergiques et medicaments les contenant
DE3775457D1 (de) Herabsetzung von sphaerolithen in polyamiden.
NO1997003I1 (no) Tirilazad mezylat
DK155782C (da) Bankemekanisme til bankning af et elektrofilters elektroder
DK578189D0 (da) Dna-sekvens
IT8421667U1 (it) Penna tascabile o da borsetta.
EP0236510A4 (de) Prostacycline und diese enthaltende arzneimittel.
FI873253A0 (fi) Acylbaerarprotein-dna-sekvens och -syntes.